Literature DB >> 12828324

Community-acquired methicillin-resistant Staphylococcus aureus: an emerging pathogen.

Battouli Saïd-Salim1, Barun Mathema, Barry N Kreiswirth.   

Abstract

The prevalence of MRSA in the nosocomial setting has been well studied, and its control remains a challenge for infection control professionals. Complicating this problem is the increasing number of reports on the spread of community-acquired MRSA (CA-MRSA). CA-MRSA strains differ from hospital-acquired MRSA (HA-MRSA) strains in that they are generally susceptible to most antibiotics. These strains share the presence of staphylococcal cassette chromosome mec (SCCmec) type IV in their genomes, are frequently virulent, and predominantly cause skin and soft tissue infections. The genome sequence of the prototypic CA-MRSA strain, MW2, revealed the presence of additional virulence factors not commonly present in other S. aureus strains. We determined the genetic relatedness of 30 geographically diverse CA-MRSA isolates clustered based on SCCmec type IV by sequence analysis of the polymorphic repeat region of the protein A gene (spa typing). These results indicated that most strains shared a common spa type (131), identical to MW2. Because this group tends to infect healthy individuals with no known risk factors for nosocomial acquisition of MRSA, we refer to it as CA-MRSA without risk factors. A second group, CA-MRSA with risk factors, consists of two related genotypes, spa types 1 and 7, which differ by one nucleotide change. These strains have caused severe infections in HIV-positive patients in Los Angeles and New York. Although CA-MRSA strains share genetic determinants, they are not clonal but rather are derived from different genetic backgrounds. The genetic characteristics and the epidemiology of CA-MRSA with and without risk factors are discussed.

Entities:  

Mesh:

Year:  2003        PMID: 12828324     DOI: 10.1086/502231

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  57 in total

1.  Community-acquired Methicillin-resistant Staphylococcus aureus: Epidemiology and Potential Virulence Factors.

Authors:  Jose M. Eguia; Henry F. Chambers
Journal:  Curr Infect Dis Rep       Date:  2003-12       Impact factor: 3.725

2.  Molecular characteristics of nosocomial and Native American community-associated methicillin-resistant Staphylococcus aureus clones from rural Wisconsin.

Authors:  Sanjay K Shukla; Mary E Stemper; Srinivas V Ramaswamy; Jennifer M Conradt; Robert Reich; Edward A Graviss; Kurt D Reed
Journal:  J Clin Microbiol       Date:  2004-08       Impact factor: 5.948

3.  Treatment and outcomes of infections by methicillin-resistant Staphylococcus aureus at an ambulatory clinic.

Authors:  John D Szumowski; Daniel E Cohen; Fumihide Kanaya; Kenneth H Mayer
Journal:  Antimicrob Agents Chemother       Date:  2006-11-20       Impact factor: 5.191

4.  Risk factors for infection and colonization with community-associated methicillin-resistant Staphylococcus aureus in the Los Angeles County jail: a case-control study.

Authors:  Cynthia L Maree; Samantha J Eells; Jennifer Tan; Elizabeth A Bancroft; Mark Malek; Nina T Harawa; Martha J Lewis; Elaine Santana; Loren G Miller
Journal:  Clin Infect Dis       Date:  2010-10-29       Impact factor: 9.079

5.  Characterization and persistence of Staphylococcus aureus strains isolated from the anterior nares and throats of healthy carriers in a Mexican community.

Authors:  Aída Hamdan-Partida; Teresita Sainz-Espuñes; Jaime Bustos-Martínez
Journal:  J Clin Microbiol       Date:  2010-03-24       Impact factor: 5.948

6.  Use of ribotyping to retrospectively identify methicillin-resistant Staphylococcus aureus isolates from phase 3 clinical trials for tigecycline that are genotypically related to community-associated isolates.

Authors:  Fionnuala McAleese; Ellen Murphy; Timothy Babinchak; Guy Singh; Battouli Said-Salim; Barry Kreiswirth; Paul Dunman; John O'Connell; Steven J Projan; Patricia A Bradford
Journal:  Antimicrob Agents Chemother       Date:  2005-11       Impact factor: 5.191

7.  The role of MRSA screening in joint-replacement surgery.

Authors:  B Sankar; P Hopgood; K M Bell
Journal:  Int Orthop       Date:  2005-04-30       Impact factor: 3.075

8.  Development of a triplex real-time PCR assay for detection of Panton-Valentine leukocidin toxin genes in clinical isolates of methicillin-resistant Staphylococcus aureus.

Authors:  Ryan R McDonald; Nick A Antonishyn; Toni Hansen; Laelie A Snook; Evelyn Nagle; Michael R Mulvey; Paul N Levett; Greg B Horsman
Journal:  J Clin Microbiol       Date:  2005-12       Impact factor: 5.948

9.  Differential distribution and expression of Panton-Valentine leucocidin among community-acquired methicillin-resistant Staphylococcus aureus strains.

Authors:  Battouli Saïd-Salim; Barun Mathema; Kevin Braughton; Stacy Davis; Daniel Sinsimer; William Eisner; Yekaterina Likhoshvay; Frank R Deleo; Barry N Kreiswirth
Journal:  J Clin Microbiol       Date:  2005-07       Impact factor: 5.948

10.  Prevalence and evolution of methicillin-resistant Staphylococcus aureus in Spanish hospitals between 1996 and 2002.

Authors:  A Vindel; P Trincado; E Gómez; R Cabrera; T Boquete; C Solá; S Valdezate; J A Saez-Nieto
Journal:  J Clin Microbiol       Date:  2006-01       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.